NTAGI meeting on vaccination for 5-12-year-olds inconclusive: Sources
India’s
vaccine think-tank the National Technical Advisory Group on Immunisation
(NTAGI) meeting to discuss vaccination protocol for 5-12 year old kids remained
inconclusive on Wednesday, according to sources.
The
NTAGI members reviewed data from vaccine makers for 5-12 year old kids, but no
decision on whether to expand the program to this younger group was taken.
Last
month the regulator had approved two vaccines--Serum Institute's Covovax and
Biological E-made Corbevax--for use in 5-12-year-old children.
However
the NTAGI decides on whether these would be used in India's Covid-19
vaccination programme.
Comments
Post a Comment